Opthea Stock (NASDAQ: OPT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 25.369K |
Day Range | - - - |
52 Wk Range | 1.600 - 4.420 |
Market Cap | $330.575M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | - |
Days to Cover | 6.74 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Opthea (NASDAQ: OPT) through any online brokerage.
Other companies in Opthea’s space includes: Inozyme Pharma (NASDAQ:INZY), Monte Rosa Therapeutics (NASDAQ:GLUE), RAPT Therapeutics (NASDAQ:RAPT), Black Diamond Therapeutic (NASDAQ:BDTX) and Nanobiotix (NASDAQ:NBTX).
The latest price target for Opthea (NASDAQ: OPT) was reported by Oppenheimer on Wednesday, September 13, 2023. The analyst firm set a price target for 16.00 expecting OPT to rise to within 12 months (a possible 301.00% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Opthea (NASDAQ: OPT) is $3.99 last updated April 5, 2024 at 4:47 PM EDT.
There are no upcoming dividends for Opthea.
Opthea’s H1 earnings are confirmed for Wednesday, February 28, 2024.
There is no upcoming split for Opthea.
Opthea is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.